Date stringdate 2012-01-01 00:00:00 2023-12-31 00:00:00 | Stock_symbol stringlengths 1 5 | Article_title stringlengths 1 255 | Article stringlengths 1 342k |
|---|---|---|---|
2022-09-01 00:00:00+00:00 | ABBV | Interesting ABBV Put And Call Options For October 14th | Investors in AbbVie Inc (Symbol: ABBV) saw new options become available today, for the October 14th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ABBV options chain for the new October 14th contracts and identified one put and one call contract of particular interest.
The put c... |
2022-09-01 00:00:00+00:00 | ABBV | 3 Dividend Stocks to Buy in September for Passive Income Generation | Do you like getting paid to do practically nothing? I thought so.
Lots of savvy investors know that they can generate heaps of passive income with dividend-paying stocks. These three businesses are more than just reliable dividend payers; they're known for raising their dividend payouts year after year. Here's how they... |
2022-08-31 00:00:00+00:00 | ABBV | Curis (CRIS) Gets FDA Nod to Partly Resume Leukemia Study | Curis, Inc. CRIS announced that it has received a notification from the FDA, wherein the regulatory body allowed the company to resume enrollment of additional patients in the monotherapy phase of the TakeAim Leukemia study.
The open-label, dose-escalation phase I/II study is evaluating Curis’ IRAK4 kinase inhibitor, e... |
2022-08-31 00:00:00+00:00 | ABBV | HDV, ABBV, VZ, PM: Large Inflows Detected at ETF | Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Core High Dividend ETF (Symbol: HDV) where we have detected an approximate $86.4 million dollar inflow -- that's a 0.7% increase week over week in outstanding units (from 119,800,000... |
2022-08-30 00:00:00+00:00 | ABBV | Amgen (AMGN) Outperforms Industry Year to Date: What's Next? | Amgen AMGN has a diverse and growing portfolio of medicines in large therapeutic categories that it expects will help it drive growth through the end of the decade despite a declining pricing environment.
Amgen stock has risen 6.4% this year so far against a decrease of 23.6% for the industry.
Image Source: Zacks Inve... |
2022-08-29 00:00:00+00:00 | ABBV | AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know | AbbVie (ABBV) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.
Over the past month, shares of this drugmaker have returned -5%, compared to the Zacks S&P 500 composite's +3.7% change. Durin... |
2022-08-29 00:00:00+00:00 | ABBV | The Zacks Analyst Blog Highlights Novartis, J&J, AbbVie, Merck and Pfizer | For Immediate Release
Chicago, IL – August 29, 2022 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Novartis NVS, J&J JNJ, AbbV... |
2022-08-26 00:00:00+00:00 | ABBV | Why Dividend Growth Stocks Should Be Part of Your Retirement Plan | If you are saving for retirement, you should aim to include not just any dividend stocks, but stocks that regularly increase their payouts over time. They can add some important stability to your portfolio as they are normally safe businesses to hold and can pay off in the long haul -- just through their dividend payme... |
2022-08-26 00:00:00+00:00 | ABBV | Pharma Stock Roundup: NVS to Spin Off Sandoz; JNJ, MRK, ABBV's FDA Updates | This week, Novartis NVS announced the planned spin-off of its generics division, Sandoz, to create a leading European generics company. The FDA granted approval to J&J JNJ and AbbVie’s ABBV cancer drug Imbruvica for a pediatric indication and gave Fast Track designation to Merck’s MRK investigational anticoagulant ther... |
2022-08-25 00:00:00+00:00 | ABBV | Do Warren Buffett's Recent Moves Spell Doom for This Group of Stocks? | Warren Buffett is frequently called the "Oracle of Omaha." An oracle, by definition, is something that provides wise counsel and often foretells the future. Buffett's uncanny ability to pick stocks that beat the market over the long term seems to justify his nickname.
So when the Oracle of Omaha sells a specific group ... |
2022-08-25 00:00:00+00:00 | ABBV | Annovis Bio (ANVS) Begins Dosing in Phase III Parkinson's Study | Annovis Bio ANVS announced the dosing of the first patient in a phase III study evaluating the company’s lead candidate, buntanetap, for the treatment of Parkinson’s Disease (PD).
The company announced top-line data from its phase IIa study of buntanetap in PD patients, treated with multiple-dose cohorts (5mg, 10mg, 20... |
2022-08-25 00:00:00+00:00 | ABBV | AbbVie (ABBV), J&J's Imbruvica Gets FDA Nod for cGVHD in Kids | AbbVie ABBV and partner J&J JNJ announced that Imbruvica, their blockbuster BTK inhibitor (BTKi) drug, has received label expansion approval from the FDA to treat chronic graft versus host disease (cGVHD) in pediatric patients.
The FDA granted approval to use Imbruvica in pediatric patients aged one year and older who ... |
2022-08-24 00:00:00+00:00 | ABBV | FDA Oks AbbVie' Imbruvica For Treatment Of Pediatric Patients With Chronic Graft Versus Host Disease | (RTTNews) - AbbVie (ABBV) said that the U.S. Food and Drug Administration approved the use of Imbruvica or ibrutinib for the treatment of pediatric patients one year and older with chronic graft versus host disease after failure of one or more lines of systemic therapy.
It is the first approved treatment option for chi... |
2022-08-24 00:00:00+00:00 | ABBV | Amgen (AMGN) Posts Positive Data from Soliris' Biosimilar Study | Amgen Inc. AMGN announced positive top-line data from the phase III study evaluating its biosimilar candidate, ABP 959, for the treatment of adult patients with paroxysmal nocturnal hemoglobinuria (“PNH”).
The DAHLIA study evaluated the safety and efficacy of ABP 959, a biosimilar candidate to Alexion’s [now part of As... |
2022-08-24 00:00:00+00:00 | ABBV | Top Stocks To Buy Now? 3 Dividend Paying Stocks To Watch Today | Are These The Top Dividend Paying Stocks To Buy Right Now?
Dividend-paying stocks have long been a popular investment, offering both income and the potential for capital gains. While most stocks do not pay dividends, there are a number of companies that have chosen to distribute a portion of their profits to shareholde... |
2022-08-24 00:00:00+00:00 | ABBV | Want Passive Income? Invest In These 3 Dividend Kings | Economic data has been mixed in recent weeks, which has led to an ongoing debate about whether the U.S. economy is in a recession. One side has the strong July jobs report to fall back on, while the other side can point to two consecutive quarters of negative gross domestic product growth. Ultimately, the official dete... |
2022-08-23 00:00:00+00:00 | ABBV | 7 Top-Rated Large-Cap Stocks to Buy and Hold | InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Top-rated large-cap stocks can offer a bit of security in volatile times.
After the relief rally earlier this month, stocks may be in for another bout of weakness. Uncertainties like inflation, rising interest rates and a potential recession have still yet ... |
2022-08-22 00:00:00+00:00 | ABBV | The 7 Best Bargain Stocks to Buy Now | InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Given the unique circumstances associated with the Covid-19 pandemic, investors may want to take a step back from the crowd and consider the best bargain stocks to buy now. To be sure, several equity-based opportunities printed much red ink this year, prese... |
2022-08-22 00:00:00+00:00 | ABBV | 2 Top Healthcare Stocks Defying the Bear Market | It's been a terrible, horrible, no good, awful past seven months on Wall Street. Most companies are feeling the effects of macroeconomic headwinds such as inflation and supply chain issues, and few are managing to perform well on the market.
Thankfully, there are some companies in the black for the year. Two companies ... |
2022-08-22 00:00:00+00:00 | ABBV | FOCUS-Hiring and data: how the U.S. will set up new Medicare drug price talks | By Ahmed Aboulenein
WASHINGTON, Aug 22 (Reuters) - The U.S. government will soon begin hiring experts and collecting the data needed to launch direct negotiations over prescription drug prices for older and disabled people, a top Biden administration official told Reuters.
President Joe Biden last week signed into law ... |
2022-08-22 00:00:00+00:00 | ABBV | Five-Star Financial Blogger Zvi Bar is Bullish on These 2 Stocks | In our “Expert Spotlight” piece today, the TipRanks Expert Center brings top picks from notable financial blogger, Zvi Bar. Zvi Bar provides advisory services to companies, trusts, and individuals, including consulting expert services regarding retirement and estate planning. Moreover, he is a practicing lawyer in the ... |
2022-08-21 00:00:00+00:00 | ABBV | Which Growth Stock Is a Better Buy Right Now -- AbbVie or InMode? | The popularity of cosmetic procedures is unquestionably on the rise. Yet two major players in the space have seen their stocks struggle this year.
Major pharmaceutical AbbVie (NYSE: ABBV) is plagued by concerns about the impending patent cliff on its top-selling drug. At the same time, healthcare equipment provider InM... |
2022-08-20 00:00:00+00:00 | ABBV | Bolster Your Social Security Benefits With These 2 Passive Income Stocks | When you're investing to boost your Social Security income in retirement, it makes the most sense to invest in companies that are capable of performing consistently and paying out for years and years, so that you don't need to worry about managing your positions. In this vein, fast growth is less important than being a... |
2022-08-19 00:00:00+00:00 | ABBV | Friday's ETF with Unusual Volume: DVOL | The First Trust Dorsey Wright Momentum & Low Volatility ETF is seeing unusually high volume in afternoon trading Friday, with over 197,000 shares traded versus three month average volume of about 26,000. Shares of DVOL were off about 0.2% on the day.
Components of that ETF with the highest volume on Friday were Procter... |
2022-08-19 00:00:00+00:00 | ABBV | Curis (CRIS) Lymphoma Study's Clinical Hold Lifted, Shares Gain | Curis CRIS shares were up 20% during market hours on Aug 18, after the company announced that the FDA has lifted the partial clinical hold on phase I/II TakeAim lymphoma study evaluating emavusertib (CA-4948) in patients with B-cell malignancies.
The open-label, dose-escalating phase I/II study is evaluating emavuserti... |
2022-08-18 00:00:00+00:00 | ABBV | Top Analyst Reports for JPMorgan Chase, AbbVie & Abbott | Thursday, August 18, 2022
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 12 major stocks, including JPMorgan Chase & Co. (JPM), AbbVie Inc. (ABBV) and Abbott Laboratories (ABT). These research reports have been hand-picked from the... |
2022-08-18 00:00:00+00:00 | ABBV | I-Mab (IMAB) Down After Partner AbbVie Revises Partnership Deal | Shares of I-Mab IMAB were down 14.3% on Aug 17 after management disclosed in an SEC filing that the company’s partner AbbVie ABBV has decided to discontinue a phase Ib study evaluating lemzoparlimab, its anti-CD47 antibody, in myelodysplastic syndrome (MDS) and acute myelocytic leukemia (AML) indications.
Though the re... |
2022-08-18 00:00:00+00:00 | ABBV | 3 Top Dividend Kings to Buy for the Long Haul | If you're hunting for stocks that you can expect to keep hiking their dividends year after year, look no further than the Dividend Kings. Every member of this elite group has a history of raising dividend payments year after year without interruption for at least 50 years, and many of the businesses are eager to do the... |
2022-08-18 00:00:00+00:00 | ABBV | Do Options Traders Know Something About AbbVie (ABBV) Stock We Don't? | Investors in AbbVie Inc. ABBV need to pay close attention to the stock based on moves in the options market lately. That is because the Aug 19, 2022 $75.00 Call had some of the highest implied volatility of all equity options today.
What is Implied Volatility?
Implied volatility shows how much movement the market is ex... |
2022-08-18 00:00:00+00:00 | ABBV | AbbVie (ABBV) Outperforms Industry This Year So Far: Here's Why | AbbVie ABBV stock has risen 4.4% this year so far compared with an increase of 0.5% for the industry.
Image Source: Zacks Investment Research
AbbVie has become one of the top-most pharma companies after it acquired Botox maker Allergan in a cash-and-stock deal for $63 billion in May 2020. The deal has transformed Abb... |
2022-08-17 00:00:00+00:00 | ABBV | Those who invested in AbbVie (NYSE:ABBV) three years ago are up 148% | The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But when you pick a company that is really flourishing, you can make more than 100%. To wit, the AbbVie Inc. (NYSE:ABBV) share price has flown 115% in the last three years. That sort of return is as solid as granite. In the last... |
2022-08-16 00:00:00+00:00 | ABBV | Roche's (RHHBY) sBLA For Polivy Combo Accepted by FDA | Roche RHHBY announced that the FDA accepted its supplemental biologics license application (sBLA). The application seeks approval for its lymphoma drug Polivy (polatuzumab vedotin) in combination with Rituxan (rituximab) plus cyclophosphamide, doxorubicin and prednisone (R-CHP) for treating adult patients with previous... |
2022-08-12 00:00:00+00:00 | ABBV | Noteworthy Friday Option Activity: SGEN, ABBV, BAC | Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Seagen Inc (Symbol: SGEN), where a total of 6,124 contracts have traded so far, representing approximately 612,400 underlying shares. That amounts to about 68.8% of SGEN's average daily trading volume over the p... |
2022-08-12 00:00:00+00:00 | ABBV | Notable ETF Outflow Detected - HDV, ABBV, IBM, PXD | Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Core High Dividend ETF (Symbol: HDV) where we have detected an approximate $119.7 million dollar outflow -- that's a 0.9% decrease week over week (from 121,400,000 to 120,250,000). A... |
2022-08-12 00:00:00+00:00 | ABBV | See Which Of The Latest 13F Filers Holds AbbVie | At Holdings Channel, we have reviewed the latest batch of the 66 most recent 13F filings for the 06/30/2022 reporting period, and noticed that AbbVie Inc (Symbol: ABBV) was held by 27 of these funds. When hedge fund managers appear to be thinking alike, we find it is a good idea to take a closer look.
Before we proceed... |
2022-08-11 00:00:00+00:00 | ABBV | Senate Finance Committee looks at Amgen taxes, widening drugmaker probe | By Michael Erman
NEW YORK, Aug 11 (Reuters) - The U.S. Senate Finance Committee is widening its investigation into the tax practices of U.S. drugmakers to include Amgen Inc AMGN.O, according to a letter sent on Thursday by the committee's chairman, Senator Ron Wyden.
Amgen is already in the crosshairs of the U.S. Inter... |
2022-08-11 00:00:00+00:00 | ABBV | September 30th Options Now Available For AbbVie (ABBV) | Investors in AbbVie Inc (Symbol: ABBV) saw new options become available today, for the September 30th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ABBV options chain for the new September 30th contracts and identified one put and one call contract of particular interest.
The p... |
2022-08-09 00:00:00+00:00 | ABBV | Few U.S. patients with hepatitis C get timely treatment, CDC says | By Mrinalika Roy
Aug 9 (Reuters) - Few U.S. adults diagnosed with hepatitis C virus infections receive timely treatment with antiviral drugs, the U.S. Centers for Disease Control and Prevention said on Tuesday.
The drugs cure hepatitis C in more than 95% of patients, but a study of more than 47,000 adults diagnosed in ... |
2022-08-09 00:00:00+00:00 | ABBV | Reata (RETA) Q2 Earnings Miss, Revenues Down Y/Y, Stock Down | Reata Pharmaceuticals, Inc. RETA reported a loss of $2.02 per share in second-quarter 2022, wider than the Zacks Consensus Estimate of a loss of $1.90.
However, the above loss included stock-based compensation and a non-cash interest expense. Adjusted loss for the quarter was $1.36 per share, wider than the loss of $1.... |
2022-08-08 00:00:00+00:00 | ABBV | Should You Buy Merck Stock After An Upbeat Q2? | Merck stock (NYSE: MRK) reported its Q2 results last week, with revenue and earnings comfortably above ours and the street estimates. However, MRK stock has seen a fall of around 4% in a week, with rising concerns over the drug pricing bill. After the recent fall, we believe MRK stock has some more room for growth and ... |
2022-08-07 00:00:00+00:00 | ABBV | 3 Unstoppable Stocks That Don't Care About the Bear Market | Whether it's thanks to a winning business model or timely good news, some companies are taking the bear market in stride, and some are even crushing it.
In particular, there are three big pharma stocks that are rising higher amid the market's decline. If you're interested in building some all-weather growth into your p... |
2022-08-06 00:00:00+00:00 | ABBV | 3 Unstoppable Dividend Stocks to Buy in August | Some dividend stocks are better than others. The differentiator is how strong the underlying businesses are that make the dividends possible.
We asked three Motley Fool contributors to pick unstoppable dividend stocks to buy in August. Here's why they chose AbbVie (NYSE: ABBV), Bristol Myers Squibb (NYSE: BMY), and Pfi... |
2022-08-05 00:00:00+00:00 | ABBV | 3 Reasons Why AbbVie Stock Could Be Approaching a Make or Break Moment | After the market's tepid reception to AbbVie's (NYSE: ABBV) latest earnings report on July 29, the drugmaker appears to face a fork in the road ahead. Down one path is the potential decline of market share for its most profitable medicine and a further drop in the stock price. The other potential path is far sunnier wi... |
2022-08-05 00:00:00+00:00 | ABBV | Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know | AbbVie (ABBV) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.
Over the past month, shares of this drugmaker have returned -8.6%, compared to the Zacks S&P 500 composite's +8.7% change. During thi... |
2022-08-05 00:00:00+00:00 | ABBV | Ironwood (IRWD) Q2 Earnings Miss, Keeps 2022 Sales Guidance | Ironwood Pharmaceuticals, Inc. IRWD reported second-quarter 2022 adjusted earnings of 21 cents per share, missing the Zacks Consensus Estimate of 31 cents. The company had reported adjusted earnings of 34 cents per share in the year-ago quarter.
Total revenues of $97.2 million missed the Zacks Consensus Estimate of $99... |
2022-08-04 00:00:00+00:00 | ABBV | Notable ETF Outflow Detected - AOR, ABBV, COST, ACN | Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Core Growth Allocation ETF (Symbol: AOR) where we have detected an approximate $77.5 million dollar outflow -- that's a 3.9% decrease week over week (from 40,000,000 to 38,450,000). ... |
2022-08-03 00:00:00+00:00 | ABBV | 7 Cheap Biotech Stocks to Buy Now | InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Biopharmaceutical companies have been struggling since 2021 and that narrative isn’t immediately changing. However, not every firm deserves this fate. In fact, investors can find great opportunities with “cheap” biotech stocks to buy now.
There are many rea... |
2022-08-03 00:00:00+00:00 | ABBV | Famed "Big Short" Investor Loves This Multibillion-Dollar Company -- Should You? | Michael Burry rose to fame by calling the 2008 housing bubble, as documented in the hit movie The Big Short. More recently, he reentered the spotlight by buying into Gamestop before it became a meme stock. Taking a hard turn from such dramatic holdings, pharmaceutical stalwart Bristol Myers Squibb (NYSE: BMY) is now on... |
2022-08-03 00:00:00+00:00 | ABBV | Is Invesco Dynamic Pharmaceuticals ETF (PJP) a Strong ETF Right Now? | The Invesco Dynamic Pharmaceuticals ETF (PJP) was launched on 06/23/2005, and is a smart beta exchange traded fund designed to offer broad exposure to the Health Care ETFs category of the market.
What Are Smart Beta ETFs?
Market cap weighted indexes were created to reflect the market, or a specific segment of the marke... |
2022-08-03 00:00:00+00:00 | ABBV | Medicare Drug Pricing Changes Could Be Coming: Time to Ditch Pharma Stocks? | Two types of stocks have performed well overall so far this year as the broader market has tanked. It makes sense that energy stocks would be up, considering the high prices of oil and natural gas. Several big pharmaceutical companies have also beaten the market in 2022 as investors viewed them as safe havens.
However,... |
2022-08-03 00:00:00+00:00 | ABBV | 1 Reason to Buy Pfizer Stock After Earnings, and 1 Reason to Sell | The year hasn't been kind to equities so far. And although many drugmakers are escaping the sell-off, Pfizer (NYSE: PFE) isn't one of them. The pharma giant is performing more or less on par with the broader market year to date. Thankfully, Pfizer's most recent quarterly update showed some very encouraging signs.
Howev... |
2022-08-03 00:00:00+00:00 | ABBV | Allegan Aesthetics Of AbbVie Gets FDA Approval For Juvederm Volux XC For Jawline Treatment | (RTTNews) - AbbVie Co.'s (ABBV) Allergan Aesthetics Wednesday announced FDA approval for its Juvederm Volux XC for improvement of jawline in adults, with moderate to a severe loss of jawline definition.
Juvederm helps in cohesivity and lift capacity to create an improved jawline that appears more defined in real life.
... |
2022-08-02 00:00:00+00:00 | ABBV | Analysts Anticipate 15% Gains Ahead For MGV | Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Vanguard Mega Cap Value ETF (Sy... |
2022-08-02 00:00:00+00:00 | ABBV | These Blue-Chip Stocks Seem Attractive at Current Levels | Despite the strong recovery in the U.S. stock market in July, investors remain wary of sky-high inflation and macro uncertainty. During these challenging times, several investors consider blue-chip stocks to be safer bets. Blue-chip stocks are stocks of large, well-established companies that have a solid track record, ... |
2022-07-31 00:00:00+00:00 | ABBV | If You Invested $25,000 in Abbott Laboratories in 2013, This Is How Much You Would Have Today | It has been more than nine years since Abbott Laboratories (NYSE: ABT) spun off AbbVie (NYSE: ABBV). By doing so, AbbVie could focus on research and developing breakthrough therapies while Abbott could remain a diversified healthcare company focused on generic pharmaceuticals, medical devices, diagnostics, and nutritio... |
2022-07-31 00:00:00+00:00 | ABBV | 3 Dividend Aristocrats to Buy in August | Track records matter. And when it comes to dividends, there's a group of stocks that have especially impressive track records. These stocks don't just reliably pay dividends; they've consistently increased their dividends for 25 or more years in a row.
I'm referring, of course, to Dividend Aristocrats. Not every member... |
2022-07-30 00:00:00+00:00 | ABBV | Earn $300 in Quarterly Retirement Dividends With 3 Easy Steps | Generating passive income through dividends is particularly important these days, as the stock market has had negative returns for the better part of a year now. But it is perhaps even more important in retirement, as that added income can come in handy. It can certainly give you some spending money to supplement your ... |
2022-07-30 00:00:00+00:00 | ABBV | 3 Stocks We Think Could Beat the Market in the Second Half of 2022 | Every investor wants alpha -- the extra return above what a benchmark index generates. Many stocks don't deliver alpha at all, but some do.
We asked three Motley Fool contributors to identify stocks they think could beat the market in the second half of the year. Here's why they chose AbbVie (NYSE: ABBV), AstraZeneca (... |
2022-07-29 00:00:00+00:00 | ABBV | AbbVie: RINVOQ Approved In EU To Treat Adults With Active Non-Radiographic Axial Spondyloarthritis | (RTTNews) - AbbVie (ABBV) announced Friday that the European Commission has approved RINVOQ (upadacitinib 15 mg, once daily) as an oral treatment for adults with Active Non-Radiographic Axial Spondyloarthritis or axSpA.
axSpA is a chronic, progressive and disabling inflammatory rheumatic disease that causes joint infla... |
2022-07-29 00:00:00+00:00 | ABBV | ABBV Crosses Below Key Moving Average Level | In trading on Friday, shares of AbbVie Inc (Symbol: ABBV) crossed below their 200 day moving average of $140.72, changing hands as low as $139.82 per share. AbbVie Inc shares are currently trading down about 6.4% on the day. The chart below shows the one year performance of ABBV shares, versus its 200 day moving averag... |
2022-07-29 00:00:00+00:00 | ABBV | AbbVie (ABBV) Q2 2022 Earnings Call Transcript | Image source: The Motley Fool.
AbbVie (NYSE: ABBV)
Q2 2022 Earnings Call
Jul 29, 2022, 9:00 a.m. ET
Contents:
Prepared Remarks
Questions and Answers
Call Participants
Prepared Remarks:
Operator
Good morning and thank you for standing by. Welcome to the AbbVie second quarter 2022earnings conference call [Operator instr... |
2022-07-29 00:00:00+00:00 | ABBV | AbbVie (ABBV) Q2 Earnings Beat Estimates | AbbVie (ABBV) came out with quarterly earnings of $3.37 per share, beating the Zacks Consensus Estimate of $3.31 per share. This compares to earnings of $3.11 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of 1.81%. A quarter ago, it was e... |
2022-07-29 00:00:00+00:00 | ABBV | Why AbbVie Stock Is Tanking Today | What happened
Shares of the Illinois-based drugmaker AbbVie (NYSE: ABBV) were down by a hefty 5% as of 2:32 p.m. ET Friday afternoon. As a result, the Dividend Aristocrat's market capitalization has slipped by a staggering $13.2 billion today.
Why are investors hitting the exits today? Ahead of the opening bell, AbbVie... |
2022-07-29 00:00:00+00:00 | ABBV | AbbVie Confirms FY22 Adj. EPS Outlook - Update | (RTTNews) - While reporting financial results for the second quarter on Friday, biopharmaceutical company AbbVie Inc. (ABBV) confirmed its adjusted earnings guidance for the full-year 2022.
For fiscal 2022, AbbVie continues to project adjusted earnings in a range of $13.78 to $13.98, which includes an unfavorable impac... |
2022-07-29 00:00:00+00:00 | ABBV | AbbVie sets aside $2 billion to settle U.S. opioid claims | Compares profit with estimates, adds share movement
July 29 (Reuters) - AbbVie Inc ABBV.N has set aside about $2 billion to resolve thousands of lawsuits against its Allergan unit over the marketing of its opioid products, the company said on Friday.
No final deal has been announced. AbbVie faces more than 3,000 lawsui... |
2022-07-29 00:00:00+00:00 | ABBV | AbbVie Q2 22 Earnings Conference Call At 9:00 AM ET | (RTTNews) - AbbVie (ABBV) will host a conference call at 9:00 AM ET on July 29, 2022, to discuss Q2 22 earnings results.
To access the live webcast, log on to https://investors.abbvie.com/events-and-presentations/upcoming-events
The views and opinions expressed herein are the views and opinions of the author and do not... |
2022-07-29 00:00:00+00:00 | ABBV | Top Stock Market News For Today July 29, 2022 | Stock Market Futures Gain Ahead Of Key Inflation Data
U.S. stock futures are trading higher early Friday morning. In general, this could be due to better-than-expected big tech earnings, and key GDP data released on Thursday. Investors will get earnings data from more notable names in the stock on Friday. Such as Chevr... |
2022-07-29 00:00:00+00:00 | ABBV | AbbVie Q2 Profit Increases, beats estimates | (RTTNews) - AbbVie (ABBV) reported a profit for its second quarter that increased from last year and beat the Street estimates.
The company's earnings came in at $924 million, or $0.51 per share. This compares with $766 million, or $0.42 per share, in last year's second quarter.
Excluding items, AbbVie reported adjuste... |
2022-07-28 00:00:00+00:00 | ABBV | Noteworthy Thursday Option Activity: RIOT, ABBV, INVH | Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Riot Blockchain Inc (Symbol: RIOT), where a total volume of 90,462 contracts has been traded thus far today, a contract volume which is representative of approximately 9.0 million underlying shares (giv... |
2022-07-28 00:00:00+00:00 | ABBV | Here's How Long It Could Realistically Take to Turn $25,000 Into $1 Million | Betting on crypto and meme stocks has made many people rich, but it's also caused significant losses for those who haven't been as lucky. Investing for the long term is safer, and it's much more likely that you'll end up with a big profit in the end. There's no sugar-coating it: It does require patience. And below, I'l... |
2022-07-28 00:00:00+00:00 | ABBV | Pfizer (PFE) Q2 Earnings and Revenues Surpass Estimates | Pfizer (PFE) came out with quarterly earnings of $2.04 per share, beating the Zacks Consensus Estimate of $1.75 per share. This compares to earnings of $1.07 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of 16.57%. A quarter ago, it was e... |
2022-07-28 00:00:00+00:00 | ABBV | Pre-Market Earnings Report for July 29, 2022 : XOM, PG, CVX, ABBV, AZN, ENB, CHTR, CL, AON, PSX, IMO, ES | The following companies are expected to report earnings prior to market open on 07/29/2022. Visit our Earnings Calendar for a full list of expected earnings releases.
Exxon Mobil Corporation (XOM)is reporting for the quarter ending June 30, 2022. The oil company's consensus earnings per share forecast from the 9 analy... |
2022-07-27 00:00:00+00:00 | ABBV | AbbVie's Allergan reaches $2 bln opioid lawsuit settlement - Bloomberg News | July 27 (Reuters) - AbbVie Inc's ABBV.N unit Allergan has reached an agreement to pay over $2 billion to resolve thousands of lawsuits related to the marketing of its opioid painkiller, Bloomberg News reported on Wednesday, citing people familiar with the matter.
The deal would settle more than 3,000 lawsuits filed by ... |
2022-07-27 00:00:00+00:00 | ABBV | Noteworthy ETF Outflows: IVE, BMY, T, ABBV | Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares S&P 500 Value ETF (Symbol: IVE) where we have detected an approximate $218.5 million dollar outflow -- that's a 0.9% decrease week over week (from 169,150,000 to 167,600,000). Among ... |
2022-07-27 00:00:00+00:00 | ABBV | Merck avoided billions in U.S. tax by offshoring Keytruda profits - senator | By Michael Erman
July 27 (Reuters) - Drugmaker Merck & Co MRK.N avoided billions of dollars of U.S. taxes in recent years on its top-selling cancer drug Keytruda by booking all the profits from the treatment outside of the United States, according to an ongoing investigation by Democrats on the Senate Finance Committee... |
2022-07-27 00:00:00+00:00 | ABBV | AbbVie Submits Regulatory Applications To FDA, EMA For Upadacitinib For Crohn's Disease In Adults | (RTTNews) - AbbVie (ABBV) Wednesday said it has submitted regulatory applications for a new indication for upadacitinib or RINVOQ, 45 mg, induction dose, and 15 mg and 30 mg, maintenance dose. The submissions are supported by phase 3 clinical trial, two induction studies and one maintenance study.
According to AbbVie, ... |
2022-07-27 00:00:00+00:00 | ABBV | 3 Supercharged Dividend Stocks to Buy if There's a Stock Market Sell-Off | When there's a market sell-off -- like in recent times -- it's a good idea to have a few dividend stocks in your portfolio. Why? Because they'll provide you with steady income even if the market continues to decline. And in better times, you'll appreciate this recurrent income too.
Today, three healthcare players have ... |
2022-07-26 00:00:00+00:00 | ABBV | Teva reaches proposed $4.35 bln settlement of U.S. opioid lawsuits | By Dietrich Knauth and Nate Raymond
July 26 (Reuters) - Teva Pharmaceutical Industries TEVA.TA on Tuesday announced a $4.35 billion proposed nationwide settlement that could resolve thousands of lawsuits over the drugmaker's alleged role in the U.S. opioid epidemic.
The proposal calls for Teva to pay state and local go... |
2022-07-26 00:00:00+00:00 | ABBV | AbbVie (ABBV) to Report Q2 Earnings: What's in the Cards? | AbbVie ABBV will report second-quarter 2022 results on Jul 29, before market open. In the last reported quarter, the company delivered an earnings surprise of 0.32%.
AbbVie’s stock has risen 11% so far this year compared with an increase of 2.8% for the industry.
Image Source: Zacks Investment Research
This large drug... |
2022-07-26 00:00:00+00:00 | ABBV | European Commission Approves AbbVie's Rinvoq To Treat Moderate To Severe Ulcerative Colitis | (RTTNews) - The European Commission approved Rinvoq (upadacitinib 45 mg and 15 mg and 30 mg) for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent, AbbVie (ABBV) s... |
2022-07-25 00:00:00+00:00 | ABBV | Will Merck Stock Rise After Its Q2 Results? | Merck (NYSE: MRK) is scheduled to report its Q2 2022 results on Thursday, July 28. We expect the company to have a robust Q2, with revenue falling in-line and earnings expected to be slightly above the consensus estimates, driven by a continued uptick in sales of its key drugs, including Keytruda, Lagevrio, and Gardasi... |
2022-07-25 00:00:00+00:00 | ABBV | 3 Dividend Kings Suited Perfectly for Income Investors | Income investing is a widely-deployed strategy within the market. After all, there are few things in life sweeter than getting paid.
Companies that consistently increase their dividend payouts are well-established in nature with successful business operations. In addition, they tend to carry a lower level of risk, undo... |
2022-07-25 00:00:00+00:00 | ABBV | Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock | AbbVie (ABBV) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.
Over the past month, shares of this drugmaker have returned -2.5%, compared to the Zacks S&P 500 composite's +5.... |
2022-07-25 00:00:00+00:00 | ABBV | The Zacks Analyst Blog Highlights J&J, Novartis, GSK, Merck and AbbVie | For Immediate Release
Chicago, IL – July 25, 2022 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: J&J JNJ, Novartis NVS, GSK pl... |
2022-07-24 00:00:00+00:00 | ABBV | 7 Value Stocks Trading at a Massive Discount Right Now | InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Value stocks have underperformed growth stocks over the past decade or so. This is due to the cheap financing available to hyper-growth businesses. Moreover, investors employed a risk-on approach towards stock picking. However, the tables have turned this y... |
2022-07-22 00:00:00+00:00 | ABBV | Pharma Stock Roundup: JNJ, NVS Q2 Earnings, GSK Consumer Unit Spin-Off | This week, J&J JNJ set in motion the second-quarter earnings season for the drug and biotech sector with an earnings and sales beat. Novartis NVS reported mixed results. GSK plc GSK completed the separation of its Consumer Healthcare (CHC) segment into a new company, Haleon. Merck’s (MRK) head and neck cancer study on ... |
2022-07-22 00:00:00+00:00 | ABBV | Zacks Value Investor Highlights: Merck, Maravai LifeSciences, Sensus Healthcare, PetIQ and AbbVie | For Immediate Release
Chicago, IL – July 22, 2022 – Zacks Value Investor is a podcast hosted weekly by Zacks Stock Strategist Tracey Ryniec. Every week, Tracey will be joined by guests to discuss the hottest investing topics in stocks, bonds and ETFs and how it impacts your life. To listen to the podcast, click here: h... |
2022-07-22 00:00:00+00:00 | ABBV | Could AbbVie Stock Help You Retire a Millionaire? | Finding a good group of stocks to invest in for the long haul can be part of a sound strategy in getting your portfolio to be worth $1 million. The more you invest, the easier it'll be to reach that target. One way to maximize your odds for success is by investing in stocks that are both growing and pay dividends.
One ... |
2022-07-21 00:00:00+00:00 | ABBV | AbbVie (ABBV) Gains But Lags Market: What You Should Know | AbbVie (ABBV) closed at $147.75 in the latest trading session, marking a +0.04% move from the prior day. The stock lagged the S&P 500's daily gain of 0.99%. Elsewhere, the Dow gained 0.51%, while the tech-heavy Nasdaq lost 0.31%.
Coming into today, shares of the drugmaker had gained 0.09% in the past month. In that sam... |
2022-07-21 00:00:00+00:00 | ABBV | 5 Cheap Healthcare Stocks in 2022 | (0:45) - Are There Value Stocks In The Healthcare Sector?
(6:00) - Tracey’s Top Stock Picks
(19:50) - Episode Roundup: MRK, MRVI, SRTS, PETQ, ABBV
Podcast@Zacks.com
Welcome to Episode #290 of the Value Investor Podcast.
Every week, Tracey Ryniec, the editor of Zacks Value Investor portfolio, shares so... |
2022-07-21 00:00:00+00:00 | ABBV | Healthcare ETFs in Focus Ahead of Q2 Earnings | The healthcare sector has gained some momentum lately on investors’ rush to safety in a volatile stock market. The sector is non-cyclical in nature, which in turn, is providing a cushion to the portfolio. Additionally, recession fears have raised the appeal for defensive bets.
As such, the ultra-popular ETFs, Health C... |
2022-07-21 00:00:00+00:00 | ABBV | 3 Steps You'll Regret Not Taking During This Bear Market | If your portfolio is teetering amid a turbulent bear market -- as pretty much everyone's is at the moment -- you need a plan to come out ahead, and you need to act on it. Fruitful investments made today could have the benefit of a very long run-up once the bear market subsides, and mistakes made out of fear could have ... |
2022-07-20 00:00:00+00:00 | ABBV | Pre-Market Most Active for Jul 20, 2022 : SDIG, APLD, TQQQ, SQQQ, SNTI, QQQ, CCL, ABT, NIO, ABBV, NCLH, F | The NASDAQ 100 Pre-Market Indicator is down -17.24 to 12,232.18. The total Pre-Market volume is currently 57,213,766 shares traded.
The following are the most active stocks for the pre-market session:
Stronghold Digital Mining, Inc. (SDIG) is +0.58 at $2.72, with 8,872,950 shares traded. As reported by Zacks, the cur... |
2022-07-20 00:00:00+00:00 | ABBV | AbbVie To Collaborate With ISTAR Medical; To Pay $60 Mln To Further Develop MINIject | (RTTNews) - AbbVie (ABBV) on Wednesday said it signed an alliance with iSTAR Medical SA, a Belgian medtech firm, to further develop and commercialize iSTAR's MINIject, a minimally invasive glaucoma surgical device.
As per the agreement, iSTAR will receive a $60 million in non-dilutive upfront payment. iSTAR will contin... |
2022-07-20 00:00:00+00:00 | ABBV | 7 Best Income Stocks to Buy Now | InvestorPlace - Stock Market News, Stock Advice & Trading Tips
While rational traders participate in the equities market to see solid returns on their investments, the present paradigm encourages everyone to consider the best income stocks to buy now. Of course, no one is going to complain about robust capital gains; T... |
2022-07-20 00:00:00+00:00 | ABBV | 3 High Yield Dividend Stocks To Watch Today | Here Are 3 Top High-Yield Dividend Stocks To Check Out Right Now
As talks of a recession continue, investors could be looking to turn to high-yield dividend stocks in the stock market today. As major indices performed poorly in the first half of the year, some investors may be searching for more conservative investment... |
2022-07-20 00:00:00+00:00 | ABBV | Biogen (BIIB) Beats on Q2 Earnings & Sales, Ups 2022 Guidance | Biogen BIIB reported second-quarter 2022 earnings per share (EPS) of $5.25, which significantly beat the Zacks Consensus Estimate of $4.10. In the year-ago quarter, Biogen had recorded earnings of $5.25 per share.
Sales came in at $2.59 billion, down 7% on a reported basis (5% on a constant currency basis) from the yea... |
2022-07-19 00:00:00+00:00 | ABBV | 3 Dividend Growth Stocks You Can Buy Now and Hold Forever | Are you worried about inflation eating into your savings? Perhaps you're nervous that the Federal Reserve's plan to fight inflation with rising interest rates will lead to a recession.
At times like these, it can seem like there aren't any good options to invest in, but this isn't the case. Plenty of well-established b... |
2022-07-19 00:00:00+00:00 | ABBV | IVW, LLY, TMO, ABBV: Large Inflows Detected at ETF | Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares S&P 500 Growth ETF (Symbol: IVW) where we have detected an approximate $86.7 million dollar inflow -- that's a 0.3% increase week over week in outstanding units (from 466,050,000 to ... |
2022-07-19 00:00:00+00:00 | ABBV | J&J (JNJ) Beats on Q2 Earnings & Sales, Lowers 2022 Guidance | Johnson & Johnson’s JNJ second-quarter 2022 earnings came in at $2.59 per share, which beat the Zacks Consensus Estimate of $2.57. Earnings increased 4.4% from the year-ago period.
Adjusted earnings exclude intangible amortization and some other special items. Including these items, J&J reported second-quarter earnings... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.